# Alexander Shulgin Research Institute

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alexander-shulgin-research-institute

- Industry: Biotechnology
- Headquarters: Lafayette, US
- Website: www.shulginresearch.net
- Total disclosed funding: $7M
- Latest round: Seed (Dec 9, 2021)
- Investors on record: 1

## About

Based in California, US, and founded in 2021 by Nicholas Vito Cozzi, Paul Freeman Daley, and L. Ann Shulgin, Alexander Shulgin Research Institute Inc. is a pharmaceutical company engages in pharmacological evaluation of psychoactive compounds. In December 9, 2021, Alexander Shulgin Research Institute Inc. raised USD 6.95 million in seed funding led by Noetic Fund and participated in the round.


The firm operates as a developer of biotechnology that focuses on psychoactive compounds known as psychedelics. The company focus on psychedelics discovery, development, and educational organization. The company provides the various services to its customers such as tailored made chemical synthesis and analysis, as well as it also provides consultation and advisory services to its various clients. Additionally, the company also engages itself in public education services like training programs, podcasts, symposiums, seminars and many more.

## Funding rounds

- Seed, Dec 9, 2021, $7M — Noetic Fund

## Investors

- Noetic Fund (https://capitalatlas.ai/funds/noetic-fund) — Seed